866-997-4948(US-Canada Toll Free)

United States Peptide Vaccine Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 113 Pages

Notes:
Sales, means the sales volume of Peptide Vaccine
Revenue, means the sales value of Peptide Vaccine

This report studies sales (consumption) of Peptide Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Artificial Cell Technologies
Benovus Bio
Bionor Pharma
Circassia
Celgene Corporation
Galena Biopharma
Immatics biotechnologies
Immune Design
ImmunoCellular Therapeutics
Invectys
ISA Pharmaceuticals
Lytix Biopharma
Medinet
Memcine Pharmaceuticals
Merck Serono
OncoTherapy Science

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Peptide Vaccine in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Peptide Vaccine Market Report 2017
1 Peptide Vaccine Overview
1.1 Product Overview and Scope of Peptide Vaccine
1.2 Classification of Peptide Vaccine
1.2.1 Type I
1.2.2 Type II
1.3 Application of Peptide Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Peptide Vaccine (2012-2022)
1.4.1 United States Peptide Vaccine Sales and Growth Rate (2012-2022)
1.4.2 United States Peptide Vaccine Revenue and Growth Rate (2012-2022)

2 United States Peptide Vaccine Competition by Manufacturers
2.1 United States Peptide Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Peptide Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Peptide Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Peptide Vaccine Market Competitive Situation and Trends
2.4.1 Peptide Vaccine Market Concentration Rate
2.4.2 Peptide Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Peptide Vaccine Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Peptide Vaccine Sales and Market Share by States (2012-2017)
3.2 United States Peptide Vaccine Revenue and Market Share by States (2012-2017)
3.3 United States Peptide Vaccine Price by States (2012-2017)

4 United States Peptide Vaccine Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Peptide Vaccine Sales and Market Share by Type (2012-2017)
4.2 United States Peptide Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Peptide Vaccine Price by Type (2012-2017)
4.4 United States Peptide Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Peptide Vaccine Sales (Volume) by Application (2012-2017)
5.1 United States Peptide Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Peptide Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Peptide Vaccine Manufacturers Profiles/Analysis
6.1 Artificial Cell Technologies
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Peptide Vaccine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Artificial Cell Technologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Benovus Bio
6.2.2 Peptide Vaccine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Benovus Bio Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Bionor Pharma
6.3.2 Peptide Vaccine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Bionor Pharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Circassia
6.4.2 Peptide Vaccine Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Circassia Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Celgene Corporation
6.5.2 Peptide Vaccine Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Celgene Corporation Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Galena Biopharma
6.6.2 Peptide Vaccine Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Galena Biopharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Immatics biotechnologies
6.7.2 Peptide Vaccine Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Immatics biotechnologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Immune Design
6.8.2 Peptide Vaccine Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Immune Design Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 ImmunoCellular Therapeutics
6.9.2 Peptide Vaccine Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 ImmunoCellular Therapeutics Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Invectys
6.10.2 Peptide Vaccine Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Invectys Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 ISA Pharmaceuticals
6.12 Lytix Biopharma
6.13 Medinet
6.14 Memcine Pharmaceuticals
6.15 Merck Serono
6.16 OncoTherapy Science

7 Peptide Vaccine Manufacturing Cost Analysis
7.1 Peptide Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Peptide Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Peptide Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Peptide Vaccine Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Peptide Vaccine Market Forecast (2017-2022)
11.1 United States Peptide Vaccine Sales, Revenue Forecast (2017-2022)
11.2 United States Peptide Vaccine Sales Forecast by Type (2017-2022)
11.3 United States Peptide Vaccine Sales Forecast by Application (2017-2022)
11.4 Peptide Vaccine Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Peptide Vaccine
Table Classification of Peptide Vaccine
Figure United States Sales Market Share of Peptide Vaccine by Type in 2015
Table Application of Peptide Vaccine
Figure United States Sales Market Share of Peptide Vaccine by Application in 2015
Figure United States Peptide Vaccine Sales and Growth Rate (2012-2022)
Figure United States Peptide Vaccine Revenue and Growth Rate (2012-2022)
Table United States Peptide Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Peptide Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Peptide Vaccine Sales Share by Manufacturers
Figure 2016 Peptide Vaccine Sales Share by Manufacturers
Table United States Peptide Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Peptide Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Peptide Vaccine Revenue Share by Manufacturers
Table 2016 United States Peptide Vaccine Revenue Share by Manufacturers
Table United States Market Peptide Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Peptide Vaccine Average Price of Key Manufacturers in 2015
Figure Peptide Vaccine Market Share of Top 3 Manufacturers
Figure Peptide Vaccine Market Share of Top 5 Manufacturers
Table United States Peptide Vaccine Sales by States (2012-2017)
Table United States Peptide Vaccine Sales Share by States (2012-2017)
Figure United States Peptide Vaccine Sales Market Share by States in 2015
Table United States Peptide Vaccine Revenue and Market Share by States (2012-2017)
Table United States Peptide Vaccine Revenue Share by States (2012-2017)
Figure Revenue Market Share of Peptide Vaccine by States (2012-2017)
Table United States Peptide Vaccine Price by States (2012-2017)
Table United States Peptide Vaccine Sales by Type (2012-2017)
Table United States Peptide Vaccine Sales Share by Type (2012-2017)
Figure United States Peptide Vaccine Sales Market Share by Type in 2015
Table United States Peptide Vaccine Revenue and Market Share by Type (2012-2017)
Table United States Peptide Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Peptide Vaccine by Type (2012-2017)
Table United States Peptide Vaccine Price by Type (2012-2017)
Figure United States Peptide Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Peptide Vaccine Sales by Application (2012-2017)
Table United States Peptide Vaccine Sales Market Share by Application (2012-2017)
Figure United States Peptide Vaccine Sales Market Share by Application in 2015
Table United States Peptide Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Peptide Vaccine Sales Growth Rate by Application (2012-2017)
Table Artificial Cell Technologies Basic Information List
Table Artificial Cell Technologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Artificial Cell Technologies Peptide Vaccine Sales Market Share (2012-2017)
Table Benovus Bio Basic Information List
Table Benovus Bio Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Benovus Bio Peptide Vaccine Sales Market Share (2012-2017)
Table Bionor Pharma Basic Information List
Table Bionor Pharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bionor Pharma Peptide Vaccine Sales Market Share (2012-2017)
Table Circassia Basic Information List
Table Circassia Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Circassia Peptide Vaccine Sales Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Celgene Corporation Peptide Vaccine Sales Market Share (2012-2017)
Table Galena Biopharma Basic Information List
Table Galena Biopharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Galena Biopharma Peptide Vaccine Sales Market Share (2012-2017)
Table Immatics biotechnologies Basic Information List
Table Immatics biotechnologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Immatics biotechnologies Peptide Vaccine Sales Market Share (2012-2017)
Table Immune Design Basic Information List
Table Immune Design Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Immune Design Peptide Vaccine Sales Market Share (2012-2017)
Table ImmunoCellular Therapeutics Basic Information List
Table ImmunoCellular Therapeutics Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table ImmunoCellular Therapeutics Peptide Vaccine Sales Market Share (2012-2017)
Table Invectys Basic Information List
Table Invectys Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Invectys Peptide Vaccine Sales Market Share (2012-2017)
Table ISA Pharmaceuticals Basic Information List
Table Lytix Biopharma Basic Information List
Table Medinet Basic Information List
Table Memcine Pharmaceuticals Basic Information List
Table Merck Serono Basic Information List
Table OncoTherapy Science Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Vaccine
Figure Manufacturing Process Analysis of Peptide Vaccine
Figure Peptide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Peptide Vaccine Major Manufacturers in 2015
Table Major Buyers of Peptide Vaccine
Table Distributors/Traders List
Figure United States Peptide Vaccine Production and Growth Rate Forecast (2017-2022)
Figure United States Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table United States Peptide Vaccine Production Forecast by Type (2017-2022)
Table United States Peptide Vaccine Consumption Forecast by Application (2017-2022)
Table United States Peptide Vaccine Sales Forecast by States (2017-2022)
Table United States Peptide Vaccine Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *